Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate if early conversion to everolimus from cyclosporine in de
novo renal transplant recipients can improve long-term renal function and slow down the
progression of chronic allograft nephropathy